Cargando…

Pathway analysis of bladder cancer genome-wide association study identifies novel pathways involved in bladder cancer development

Genome-wide association studies (GWAS) are designed to identify individual regions associated with cancer risk, but only explain a small fraction of the inherited variability. Alternative approach analyzing genetic variants within biological pathways has been proposed to discover networks of suscept...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Meng, Rothman, Nathaniel, Ye, Yuanqing, Gu, Jian, Scheet, Paul A., Huang, Maosheng, Chang, David W., Dinney, Colin P., Silverman, Debra T., Figueroa, Jonine D., Chanock, Stephen J., Wu, Xifeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059113/ https://www.ncbi.nlm.nih.gov/pubmed/27738493 http://dx.doi.org/10.18632/genesandcancer.113

Ejemplares similares

Genetic Variations in the Transforming Growth Factor Beta Pathway as Predictors of Bladder Cancer Risk
por: Wei, Hua, et al.
Publicado: (2012)

Genetic Variants in Telomere-Maintenance Genes and Bladder Cancer Risk
por: Chang, Joshua, et al.
Publicado: (2012)

Serum microRNAs as predictors of risk for non-muscle invasive bladder cancer
por: Lian, Jie, et al.
Publicado: (2018)

Genetic variants in the inflammation pathway as predictors of recurrence and progression in non-muscle invasive bladder cancer treated with Bacillus Calmette–Guérin
por: Williams, Stephen B., et al.
Publicado: (2017)

Large-Scale Evaluation of Candidate Genes Identifies Associations between VEGF Polymorphisms and Bladder Cancer Risk
por: García-Closas, Montserrat, et al.
Publicado: (2007)

Genetic Variation in the TP53 Pathway and Bladder Cancer Risk. A Comprehensive Analysis
por: Pineda, Silvia, et al.
Publicado: (2014)

Polymorphisms in GSTT1, GSTZ1, and CYP2E1, Disinfection By-products, and Risk of Bladder Cancer in Spain
por: Cantor, Kenneth P., et al.
Publicado: (2010)

Large-Scale Pathway-Based Analysis of Bladder Cancer Genome-Wide Association Data from Five Studies of European Background
por: Menashe, Idan, et al.
Publicado: (2012)

Genome-wide CNV analysis replicates the association between GSTM1 deletion and bladder cancer: a support for using continuous measurement from SNP-array data
por: Marenne, Gaëlle, et al.
Publicado: (2012)

Intrinsic subtypes and bladder cancer metastasis
por: McConkey, David J., et al.
Publicado: (2016)

Risk based neoadjuvant chemotherapy in muscle invasive bladder cancer
por: Jayaratna, Isuru S., et al.
Publicado: (2015)

Application of Multi-SNP Approaches Bayesian LASSO and AUC-RF to Detect Main Effects of Inflammatory-Gene Variants Associated with Bladder Cancer Risk
por: de Maturana, Evangelina López, et al.
Publicado: (2013)

A novel functional variant in 8q24 is associated with regulation of prostate stem cell antigen (PSCA) gene expression and bladder cancer risk
por: Fu, Yi-Ping, et al.
Publicado: (2011)

Interferon gene therapy with nadofaragene firadenovec for bladder cancer: from bench to approval
por: Martini, Alberto, et al.
Publicado: (2023)

Bladder cancer and the Notch pathway
por: Fernandez-Marcos, Pablo J., et al.
Publicado: (2015)

Identification and replication of the interplay of four genetic high-risk variants for urinary bladder cancer
por: Selinski, Silvia, et al.
Publicado: (2017)

Association of Polymorphisms in Oxidative Stress Genes with Clinical Outcomes for Bladder Cancer Treated with Bacillus Calmette-Guérin
por: Wei, Hua, et al.
Publicado: (2012)

A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci
por: Rothman, Nathaniel, et al.
Publicado: (2010)

Role of the JNK Pathway in Bladder Cancer
por: Lee, Eun Hye, et al.
Publicado: (2022)

Disinfection By-Products in Drinking Water and Bladder Cancer: Evaluation of Risk Modification by Common Genetic Polymorphisms in Two Case–Control Studies
por: Beane Freeman, Laura E., et al.
Publicado: (2022)

HSD3B and Gene-Gene Interactions in a Pathway-Based Analysis of Genetic Susceptibility to Bladder Cancer
por: Andrew, Angeline S., et al.
Publicado: (2012)

Detection of Bladder Cancer Using Proteomic Profiling of Urine Sediments
por: Majewski, Tadeusz, et al.
Publicado: (2012)

Multilevel-analysis identify a cis-expression quantitative trait locus associated with risk of renal cell carcinoma
por: Shu, Xiang, et al.
Publicado: (2015)

DNA Repair Pathway Alterations in Bladder Cancer
por: Mouw, Kent W.
Publicado: (2017)

Total Fluid and Water Consumption and the Joint Effect of Exposure to Disinfection By-Products on Risk of Bladder Cancer
por: Michaud, Dominique S., et al.
Publicado: (2007)

Programmed death-ligand 1 signaling pathway involves in bladder cancer growth and progression
por: Samishina, Elena A., et al.
Publicado: (2019)

Fluid intake, genetic variants of UDP-glucuronosyltransferases, and bladder cancer risk
por: Wang, J, et al.
Publicado: (2013)

Prediction of non-muscle invasive bladder cancer outcomes assessed by innovative multimarker prognostic models
por: López de Maturana, E., et al.
Publicado: (2016)

Bladder Cancer Recovery Pathways: A Systematic Review
por: Maloney, Ian, et al.
Publicado: (2017)

Emerging role of Hippo signalling pathway in bladder cancer
por: Xia, Jianling, et al.
Publicado: (2017)

Targetable Pathways in Advanced Bladder Cancer: FGFR Signaling
por: Xiao, Jin-Fen, et al.
Publicado: (2021)

Clinical potential of the Hippo-YAP pathway in bladder cancer
por: Cheng, Xin, et al.
Publicado: (2022)

Bladder-sparing Treatment in Patients with Bacillus Calmette-Guerin–unresponsive Non–muscle-invasive Bladder Cancer: An Analysis of Long-term Survival Outcomes
por: Tan, Wei Shen, et al.
Publicado: (2023)

Assessment of Luminal and Basal Phenotypes in Bladder Cancer
por: Guo, Charles C., et al.
Publicado: (2020)

Deficiency of Mettl3 in Bladder Cancer Stem Cells Inhibits Bladder Cancer Progression and Angiogenesis
por: Wang, Ganping, et al.
Publicado: (2021)

Specific micro-RNA expression patterns distinguish the basal and luminal subtypes of muscle-invasive bladder cancer
por: Ochoa, Andrea E., et al.
Publicado: (2016)

Letter to the Editor: Bacillus Calmette-Guerin (BCG) Treatment Failures with Non-Muscle Invasive Bladder Cancer: A Data-Driven Definition for BCG Unresponsive Disease
por: Li, Roger, et al.
Publicado: (2017)

Exposure to benzene and other hydrocarbons and risk of bladder cancer among male offshore petroleum workers
por: Shala, Nita K., et al.
Publicado: (2023)

LINE-1 methylation in granulocyte DNA and trihalomethane exposure is associated with bladder cancer risk
por: Salas, Lucas A, et al.
Publicado: (2014)

Corrigendum: Deficiency of Mettl3 in Bladder Cancer Stem Cells Inhibits Bladder Cancer Progression and Angiogenesis
por: Wang, Ganping, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3ooco93qcjek92skeb0drm5k1c